Leucine-rich repeat kinase 2 (LRRK2) interacts with vacuolar protein sorting 35 (Vps35) to regulate autophagy

被引：0
|
作者：
Linhart, R.
Ho, Y. J.
Kaing, D.
Hou, E.
Sohal, D.
Eismati, R.
Rosales, J.
Fedrizzi, R.
Tsang, A.
Fong, D.
Dawson, A.
Venderova, K.
机构：
来源：
MOVEMENT DISORDERS | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1041
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [31] Inhibitors of Leucine-Rich Repeat Kinase 2 (LRRK2): Progress and Promise for the Treatment of Parkinson's Disease
    Gilligan, Paul J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (10) : 927 - 938
  • [32] Leucine-rich repeat kinase 2 (LRRK2) impairs function of the retromer-associated WASH complex
    Venderova, K.
    Kaing, D.
    Eismati, R.
    Joseph, R.
    Radek, L.
    Yu-Ju, H.
    Emily, H.
    Ariel, T.
    Ryan, F.
    Derek, F.
    MOVEMENT DISORDERS, 2015, 30 : S412 - S412
  • [33] Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson's disease
    Kluss, Jillian H.
    Lewis, Patrick A.
    Greggio, Elisa
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (06) : 537 - 546
  • [34] A meta-analysis of leucine-rich repeat kinase 2 (LRRK2) polymorphisms in Alzheimer's disease
    Fatahian, Reza
    Bagheri, Seyed Reza
    Sadeghi, Masoud
    FOLIA NEUROPATHOLOGICA, 2019, 57 (01) : 1 - 5
  • [35] The Role of the Leucine-Rich Repeat Kinase 2 (LRRK2) in Development and Severity of Inflammatory Bowel Disease (IBD)
    Gruber, Sven
    Frey-Wagner, Isabelle
    Wang, Yu
    Cee, Alexandra
    Leonardi, Irina
    Lang, Silvia
    Bettoni, Carla
    Shimshek, Derya R.
    van der Putten, Herman
    Rogler, Gerhard
    Wagner, Carsten A.
    GASTROENTEROLOGY, 2013, 144 (05) : S441 - S441
  • [36] Cerebrospinal Fluid Biomarkers and Clinical Features in Leucine-Rich Repeat Kinase 2 (LRRK2) Mutation Carriers
    Vilas, Dolores
    Shaw, Leslie M.
    Taylor, Peggy
    Berg, Daniela
    Brockmann, Kathrin
    Aasly, Jan
    Marras, Connie
    Pont-Sunyer, Claustre
    Rios, Jose
    Marek, Ken
    Tolosa, Eduardo
    MOVEMENT DISORDERS, 2016, 31 (06) : 906 - 914
  • [37] Leucine-rich repeat kinase 2 (LRRK2) mRNA expression in the mouse brain: effects of dopamine depletion
    Higashi, S.
    Arai, H.
    Colebrooke, R.
    Ros-Bernal, F.
    Xia, J.
    Lynch, P.
    Herrero, M. T.
    Emson, P. C.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 117 - 117
  • [38] Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors
    Gulati, Anmol
    Yeung, Charles S.
    Lapointe, Blair
    Kattar, Solomon D.
    Gunaydin, Hakan
    Scott, Jack D.
    Childers, Kaleen K.
    Methot, Joey L.
    Simov, Vladimir
    Kurukulasuriya, Ravi
    Pio, Barbara
    Morriello, Greg J.
    Liu, Ping
    Tang, Haiqun
    Neelamkavil, Santhosh
    Wood, Harold B.
    Rada, Vanessa L.
    Ardolino, Michael J.
    Yan, Xin Cindy
    Palte, Rachel
    Otte, Karin
    Faltus, Robert
    Woodhouse, Janice
    Hegde, Laxminarayan G.
    Ciaccio, Paul
    Minnihan, Ellen C.
    DiMauro, Erin F.
    Fell, Matthew J.
    Fuller, Peter H.
    Ellis, J. Michael
    RSC MEDICINAL CHEMISTRY, 2021, 12 (07): : 1164 - 1173
  • [39] Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson’s disease
    Julie P. Taylor
    Mary M. Hulihan
    Jennifer M. Kachergus
    Heather L. Melrose
    Sarah J. Lincoln
    Kelly M. Hinkle
    Jeremy T. Stone
    Owen A. Ross
    Robert Hauser
    Jan Aasly
    Thomas Gasser
    Haydeh Payami
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2007, 8 : 95 - 102
  • [40] The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
    Guo, Luxuan
    Gandhi, Payal N.
    Wang, Wen
    Petersen, Robert B.
    Wilson-Delfosse, Amy L.
    Chen, Shu G.
    EXPERIMENTAL CELL RESEARCH, 2007, 313 (16) : 3658 - 3670
12345